Monthly Archives: November 2016

 Biopharmaceutical News Week # 2016.46

     Biopharmaceutical News Week # 2016.46   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation       Zika Virus   Researchers from the Wistar Institute (Philadelphia, PA, USA) have tested a synthetic DNA vaccine that protected 100% of vaccinated animals from Zika infection. There is no approved vaccine or therapy against Zika, but the candidate, […]

read more

 Biopharmaceutical News Week # 2016.44/45

   Biopharmaceutical News Week # 2016.44/45   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation       US Elections       Editor’s Note   Republican Donald Trump’s unexpected victory for many analysts, combined with the Grand Old Party (GOP) retention of control of the US Senate and the House will force the healthcare industry to […]

read more

 Biopharmaceutical News Week # 2016.43

     Biopharmaceutical News Week # 2016.43   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation,   jcm9144@gmail.com       Zika Virus   Sanofi enters into a collaboration with Brazil’s Fiocruz public health center in order to speed up the development of its Zika vaccine.   Heat Biologics (Durham, NC, USA) has entered into an agreement with […]

read more

 Biopharmaceutical News Week # 2016.42

  Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation,   jcm9144@gmail.com       Mergers, Acquisitions and Joint Ventures   Teva Pharmaceuticals is now considering acquiring biosimilar Celltrion (Seoul, South Korea). “We will continue to investigate such opportunities as we balance risk and seek complementary skills in our partners," said Mr Yonatan Beker, director of corporate reputation. Recently […]

read more

 Biopharmaceutical News Week # 2016.41

       Biopharmaceutical News Week # 2016.41   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation,   jcm@btobioinnovation.com           Editor’s Note   We have lately encountered a series of events (breakdown of our main frame computer, limited access to our data base and complete shutdown of our business mail) which obliged us to cancel recent […]

read more

Biopharmaceutical News Week # 2016.37

 Biopharmaceutical News Week # 2016.37     Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation, jcm@btobioinnovation.com    Editor’s Note   We have received an interesting number of positive, encouraging and motivating replies to our enquiry concerning the future of this biopharmaceutical newsletter, although the total number of replies received came at the low end of our expectations. The […]

read more